Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Consolidated Net Profit

    Back to Income Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹18 Cr₹-186 Cr₹376 Cr₹835 Cr

What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?

The latest Consolidated Net Profit ratio of PIRAMAL PHARMA is ₹18 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹18 Cr
Mar2023₹-186 Cr
Mar2022₹376 Cr
Mar2021₹835 Cr

How is Consolidated Net Profit of PIRAMAL PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹18 Cr
Positive
Mar2023 ₹-186 Cr
Negative
Mar2022 ₹376 Cr
-54.98
Mar2021 ₹835 Cr -

Compare Consolidated Net Profit of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹28,039.5 Cr 3.6% 1.5% 42.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,519.0 Cr 1.6% -2.9% 17.2% Stock Analytics
DIVIS LABORATORIES ₹175,903.0 Cr 1.5% 10.4% 51.9% Stock Analytics
CIPLA ₹121,669.0 Cr 2.3% 1.9% 2.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,097.0 Cr 5.7% 14.1% 15.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,605.0 Cr 1.4% 1.3% 17% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

3.6%

1.5%

42.7%

SENSEX

1.3%

2.6%

7.8%


You may also like the below Video Courses